◆英語タイトル：MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis Review
MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product includes MOR208, MOR202, MOR103, MOR106, and MOR107. It drugs are used for the treatment of various types of cancers, psoriasis, rheumatoid arthritis, chronic obstructive pulmonary disease, asthma, solid tumors, eye disease, and other inflammatory diseases. Morphosys offers human combinatorial antibody library (HuCAL), a recombinant antibody technology which allows generation of therapeutic and diagnostic antibodies. The company provides clinical trials for cancer and inflammatory disorders. It also conducts research and development activities with pharmaceutical and biotechnology companies. The company owns a regional licensing agreement to develop and commercialize products in China, Taiwan, Hong Kong, and Macao. Morphosys is headquartered in Munich, Germany.
MorphoSys AG Key Recent Developments
Feb 19,2019: Simon Moroney, CEO and co-founder of MorphoSys, announces his intention to retire
Nov 05,2018: MorphoSys announces third quarter 2018 results
Sep 17,2018: Morphosys and LEO Pharma expand strategic alliance to develop peptide-derived therapeutics
Sep 06,2018: MorphoSys to be listed in MDAX
Aug 02,2018: MorphoSys reports second quarter 2018 financial results
This comprehensive SWOT profile of MorphoSys AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MorphoSys AG including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
MorphoSys AG – Key Information
MorphoSys AG – Overview
MorphoSys AG – Key Employees
MorphoSys AG – Key Employee Biographies
MorphoSys AG – Key Operational Heads
MorphoSys AG – Major Products and Services
MorphoSys AG – History
MorphoSys AG – Company Statement
MorphoSys AG – Locations And Subsidiaries
MorphoSys AG – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
MorphoSys AG – Business Description
MorphoSys AG – Corporate Strategy
MorphoSys AG – SWOT Analysis
SWOT Analysis – Overview
MorphoSys AG – Strengths
MorphoSys AG – Weaknesses
MorphoSys AG – Opportunities
MorphoSys AG – Threats
MorphoSys AG – Key Competitors
Section 3 – Company Financial Performance Charts
MorphoSys AG – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
MorphoSys AG, Key Information
MorphoSys AG, Key Ratios
MorphoSys AG, Share Data
MorphoSys AG, Major Products and Services
MorphoSys AG, History
MorphoSys AG, Key Employees
MorphoSys AG, Key Employee Biographies
MorphoSys AG, Key Operational Heads
MorphoSys AG, Other Locations
MorphoSys AG, Subsidiaries
MorphoSys AG, Key Manufacturing facilities
MorphoSys AG, Key Competitors
MorphoSys AG, SWOT Analysis
MorphoSys AG, Ratios based on current share price
MorphoSys AG, Annual Ratios
MorphoSys AG, Interim Ratios
Capital Market Ratios
List of Figures
MorphoSys AG, Performance Chart
MorphoSys AG, Ratio Charts